SCHEMBL4947800

SCHEMBL4947800

N#Cc1cnc2sc(C(=O)O)cc2c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.40
DAO P14920 2/20 0.38
NOTUM Q6P988 3/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
XDH P47989 1/20 0.34
PLK4 O00444 1/20 0.34
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
CHEK2 O96017 1/20 0.34
CDK1 P06493 1/20 0.34
PIM1 P11309 1/20 0.34
PRKACA P17612 1/20 0.34
CDK2 P24941 1/20 0.34
MAPK9 P45984 1/20 0.34
CSNK1D P48730 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4947269 0.88 CSNK2A2 (0.45) CCNCCDK8ALDH1A1KDM4ECSNK1D
SCHEMBL4947940 0.80 CSNK1A1 (0.36) ALDH1A1CYP11B2
SCHEMBL4948258 0.79 PRKCQ (0.43) SLC22A12
SCHEMBL4948267 0.79 PRKCQ (0.43) SLC22A12
SCHEMBL3996010 0.77 CYP2A6 (0.35) ALDH1A1
SCHEMBL3993667 0.77 CSNK1A1 (0.34) ALDH1A1
SCHEMBL30727714 0.77 CYP2A6 (0.35) ALDH1A1
SCHEMBL3992555 0.77 CSNK1A1 (0.34) NOTUMALDH1A1CSNK2A1MEN1KMT2A
SCHEMBL4948103 0.77 CYP2A6 (0.36)
SCHEMBL3994723 0.74 PRKCQ (0.54) ALDH1A1KDM4EMEN1PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937690-A1 THIENO[2,3-B]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS Wyeth a Corporation of the State of Delaware (US) 2008-07-02 EP disclosed
US-20070082880-A1 Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors WYETH 2007-04-12 US disclosed
WO-2007038519-A1 THIENO[2,3-B]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS WYETH (US) 2007-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082880-A1 Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors MAP4K2, CNKSR1, MAP3K1 SLC22A12 4768/4885DAO 1609/4885NOTUM 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.